A detailed history of Round Rock Advisors, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Round Rock Advisors, LLC holds 21,556 shares of CDXC stock, worth $132,353. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,556
Holding current value
$132,353
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
N/A
21,556 New
21,556 $132,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $420M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Round Rock Advisors, LLC Portfolio

Follow Round Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Round Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Round Rock Advisors, LLC with notifications on news.